查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378846

核酸检测市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Nucleic Acid Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球核酸检测市场规模达到29亿美元。展望未来， IMARC Group预计到2028年市场规模将达到42亿美元，2022-2028年复合年增长率（CAGR）为6.4%。

核酸检测（NAT）是指筛检患者血液、组织或尿液中病毒、细菌或致病性核酸的分子技术。它用于法医检测并诊断输血传染感染、遗传性疾病和癌症。它涉及透过核酸 (NA) 萃取、目标 NA 扩增和目标扩增子 NA 检测来合併样本。测试涉及用于执行聚合酶炼式反应(PCR)、链置换扩增(SDA)、连接酶炼式反应(LCR)、转录介导的扩增(TMA) 和基于NA 序列的扩增(NASBA)过程的试剂盒和耗材。 NAT 也用于识别没有明显症状的疾病并解决错误的反应性解释。

全球性传染性细菌和病毒性疾病的日益普及是推动市场成长的关键因素之一。此外，对先进诊断系统的需求不断增长也推动了市场的成长。与此一致的是，冠状病毒病（COVID-19）的爆发也增加了对检测抗原的 NAT 解决方案的需求。 NAT 广泛用于传染病的有效管理和感染源的准确识别。此外，各种技术进步，例如新型生物诊断技术（包括讯号和探针放大系统）的发展，也是其他生长诱导因素。这些创新技术有助于及早发现疾病并最大限度地缩短病毒的传染期。其他因素，包括广泛的研发（R&D）活动以及医疗保健基础设施的改善，预计将进一步推动市场发展。

本报告回答的关键问题：

  • 迄今为止，全球核酸检测市场表现如何，未来几年又将如何表现？
  • COVID-19对全球核酸检测市场有何影响？
  • 主要区域市场有哪些？
  • 依产品类型分類的市场是怎么样的？
  • 基于技术的市场区隔是什么？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球核酸检测市场格局如何？主要参与者是谁？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球核酸检测市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依产品类型分類的市场区隔

  • 仪器
    • 市场走向
    • 市场预测
  • 试剂及耗材
    • 市场走向
    • 市场预测

第 7 章：依科技分類的市场

  • TMA- 转录介导的扩增
    • 市场走向
    • 市场预测
  • PCR-聚合酶炼式反应
    • 市场走向
    • 市场预测
  • LCR-连接酶炼式反应
    • 市场走向
    • 市场预测
  • SDA- 链位移放大
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：最终用户的市场区隔

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 病理实验室
    • 市场走向
    • 市场预测
  • 研究机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Agilent Technologies
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd.
    • Illumina Inc.
    • Merck KGaA
    • Siemens Healthcare
    • Tecan Group AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A2902

Abstract

The global nucleic acid testing market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2022-2028.

Nucleic acid testing (NAT) refers to a molecular technique for screening viruses, bacteria or pathogenic nucleic acid in the blood, tissue or urine of the patient. It is conducted for forensic testing and to diagnose transfusion-transmitted infections, genetic diseases and cancer. It involves sample pooling through nucleic acid (NA) extraction, target NA amplification and target amplicon NA detection. The testing involves kits and consumables for performing polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA) and NA sequence-based amplification (NASBA) processes. NAT is also used for the identification of diseases with no visible symptoms and resolving false reactive interpretations.

The increasing prevalence of infectious bacterial and viral diseases across the globe represents one of the key factors driving the growth of the market. Furthermore, the increasing demand for advanced diagnostic systems is also driving the market growth. In line with this, the onset of the coronavirus disease (COVID-19) has also enhanced the demand for NAT solutions to detect the antigens. NAT is widely used for the effective management of communicable diseases and accurate identification of the infecting agent. Additionally, various technological advancements, such as the development of novel biological diagnostic techniques, including signal and probe amplification systems, are acting as other growth-inducing factors. These innovative techniques aid in the early detection of the disease and minimizing the infectious period of the virus. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global nucleic acid testing market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product type, technology and end user.

Breakup by Product Type:

Instruments

Reagents and Consumables

Breakup by Technology:

TMA- Transcription-mediated Amplification

PCR- Polymerase Chain Reaction

LCR- Ligase Chain Reaction

SDA- Strand Displacement Amplification

Others

Breakup by End User:

Hospitals and Clinics

Pathology Laboratories

Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, Siemens Healthcare, Tecan Group AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global nucleic acid testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global nucleic acid testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global nucleic acid testing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nucleic Acid Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 TMA- Transcription-mediated Amplification
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 PCR- Polymerase Chain Reaction
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 LCR- Ligase Chain Reaction
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 SDA- Strand Displacement Amplification
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pathology Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Becton, Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Rad Laboratories Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Danaher Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Illumina Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Siemens Healthcare
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Tecan Group AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Nucleic Acid Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Nucleic Acid Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Nucleic Acid Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Nucleic Acid Testing Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Nucleic Acid Testing Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Nucleic Acid Testing Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Nucleic Acid Testing Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Nucleic Acid Testing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Nucleic Acid Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Nucleic Acid Testing (Reagents and Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Nucleic Acid Testing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Nucleic Acid Testing (TMA- Transcription-mediated Amplification) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Nucleic Acid Testing (TMA- Transcription-mediated Amplification) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Nucleic Acid Testing (PCR- Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Nucleic Acid Testing (PCR- Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Nucleic Acid Testing (LCR- Ligase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Nucleic Acid Testing (LCR- Ligase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Nucleic Acid Testing (SDA- Strand Displacement Amplification) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Nucleic Acid Testing (SDA- Strand Displacement Amplification) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Nucleic Acid Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Nucleic Acid Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Nucleic Acid Testing (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Nucleic Acid Testing (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Nucleic Acid Testing (Pathology Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Nucleic Acid Testing (Pathology Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Nucleic Acid Testing (Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Nucleic Acid Testing (Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Nucleic Acid Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Nucleic Acid Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: United States: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Canada: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Canada: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: North America: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: China: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Japan: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Japan: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: India: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: India: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: South Korea: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: South Korea: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Australia: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Australia: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Indonesia: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Indonesia: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Others: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Others: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Asia-Pacific: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Germany: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: France: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: France: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: United Kingdom: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: United Kingdom: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Italy: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Italy: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Spain: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Spain: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Russia: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Russia: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Europe: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Brazil: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Mexico: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Mexico: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Nucleic Acid Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Nucleic Acid Testing Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Nucleic Acid Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Nucleic Acid Testing Industry: SWOT Analysis
  • Figure 80: Global: Nucleic Acid Testing Industry: Value Chain Analysis
  • Figure 81: Global: Nucleic Acid Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nucleic Acid Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Nucleic Acid Testing Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Nucleic Acid Testing Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Nucleic Acid Testing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Nucleic Acid Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Nucleic Acid Testing Market: Competitive Structure
  • Table 7: Global: Nucleic Acid Testing Market: Key Players